Gramicidin inhibits human gastric cancer cell proliferation, cell cycle and induced apoptosis

Tingting Chen1, Yong Wang2, Yang Yang1

  • 1Department of Medical Oncology, First Affiliated Hospital of Bengbu Medical College, Anhui Province Key Laboratory of Translational Cancer Research (Bengbu Medical College), 287 Changhuai Road, Bengbu, 233004, Anhui Province, People's Republic of China.

Biological Research
|November 27, 2019
PubMed
Abstract

Insights

Gramicidin exhibits anti-tumor effects against gastric cancer cells by inhibiting proliferation, migration, and inducing apoptosis. This peptide antibiotic shows potential for clinical application in treating gastric cancer.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Gastric cancer presents a significant global health challenge due to high morbidity and mortality.
  • Gramicidin, a peptide antibiotic, is primarily known for its antimicrobial properties.
  • The anti-cancer potential of gramicidin on gastric cancer remains largely unexplored.

Purpose of the Study:

  • To investigate the anti-cancer effects of gramicidin on human gastric cancer cells.
  • To elucidate the underlying mechanisms of gramicidin's action in gastric cancer.
  • To evaluate gramicidin's potential as a therapeutic agent for gastric cancer.

Main Methods:

  • Cell viability was assessed using CCK-8 assays.
  • Cell proliferation was evaluated through colony formation assays.
  • Cell migration, apoptosis, cell cycle, and protein expression (cyclinD1, Bcl-2, FoxO1 phosphorylation) were analyzed using wound healing, apoptosis/cell cycle analysis, and Western blot.

Main Results:

  • Gramicidin demonstrated significant toxicity to gastric cancer cells (SGC-7901, BGC-823) while sparing normal gastric mucosal cells (GES-1).
  • Gramicidin inhibited gastric cancer cell proliferation, migration, and induced apoptosis, with observed G2/M cell cycle arrest.
  • Down-regulation of cyclinD1, Bcl-2, and FoxO1 phosphorylation was observed following gramicidin treatment.

Conclusions:

  • Gramicidin exhibits significant anti-tumor activity against gastric cancer cells in vitro.
  • Gramicidin's mechanism involves inhibiting proliferation and migration, inducing apoptosis, and affecting key cell cycle and survival proteins.
  • These findings suggest gramicidin as a potential candidate for clinical application in gastric cancer treatment.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K